| Fiscal Year End | Company Status | Exempt Flag |
| December 31 | Suspend | N |
|
|
|
|
|
| Incorporation Locations |
| Inc. Date | Expiry Date | Country | Region | Description |
| 21/Jun/2011 | | Canada | Alberta | |
|
|
| Exchange Filing Office |
| Location |
| NEX Service Office |
|
|  |
| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| Medical Devices Manufacturing
| Business of the Corporation (From News Release July 23, 2013)
The Corporation's business is centered on the commercialization of the RAPID-B diagnostic system, which is an integrated system of hardware, software and chemical reagents that tests bacteria in key environments. This technology could have potentially diverse applicability from food safety to clinical diagnostics, by identifying and quantifying microorganism levels more rapidly and with greater precision than currently employed techniques.
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| VBI.H | Vivione Biosciences Inc. | TSX Venture | SUSPEND |
|
|
| Name History | From | To |
| Vivione Biosciences Inc. | 23/Jul/2013 | Present |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| Spring 2015 CFR | 26/Mar/2015 |
|
|
|
|
|
